Furthermore, follow‐up information of 371 HCC patients from the TCGA database and 24 HCC patients enrolled in the research were analysed and found that patients with high STRN3 expression had poorer outcomes, confirming its' clinical value in predicting the prognosis of HCC patients. This evidence concerns the gene STRN3 and hepatocellular carcinoma.